Medications

Zoledronic acid linked to early increase in sclerostin levels

(HealthDay)—Women with postmenopausal osteoporosis treated with zoledronic acid show an early increase in serum levels of the negative regulator of bone formation, sclerostin, that return close to baseline after 360 days, ...

Medications

Common osteoporosis drug slows formation of new bone

Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study accepted for publication in The Endocrine Society's Journal ...

Diseases, Conditions, Syndromes

Simple reminders may help prevent fractures

Reminding primary care doctors to test at-risk patients for osteoporosis can prevent fractures and reduce health care costs, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical ...

Diseases, Conditions, Syndromes

Osteoporosis costs EU countries 37 billion every year

A new report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations, is the first to describe in detail the epidemiology, burden, ...

Oncology & Cancer

Routine CT imaging can be used to identify osteoporosis

(HealthDay)—Abdominal computed tomography (CT) imaging, conducted for other indications, can be used to identify patients with osteoporosis, according to a study published in the April 16 issue of the Annals of Internal ...

page 29 from 38